TLGT News and Press, Teligent Inc. From 03/18/19

Teligent ( TLGT ) Q4 results : Revenues: $16.8M (+13.5%). More news on: Teligent, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...

Teligent (NASDAQ: TLGT ): Q4 Non-GAAP EPS of -$0.18 misses by $0.15 ; GAAP EPS of -$0.27. More news on: Teligent, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

BUENA, N.J., March 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the fourth quarter and year ended December 31, 2018. Fourth Quarter 2018 Highlights Net revenues of $...

BUENA, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at 31 st Annual ROTH Conference March 19, 2019. The Conference is taking place March 17 th - March 19 th , 2019 at the Ritz Carlto...

BUENA, N.J., March 14, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FD...

Thinly traded nano cap Teligent ( TLGT +15.1% ) is up on more than a 5x surge in volume on no particular news. More news on: Teligent, Inc., Healthcare stocks news, Stocks on the move, Read more ...

BUENA, N.J., March 12, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 8:00am ET on Monday, March 18 th , 2019 to discuss the 4 th  quarter 2018 financial results an...

BUENA, N.J., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at The 8 th Annual SVB Leerink Global Healthcare Conference March 1, 2019. The Conference is taking place February 27 th -March 1 st...

Gainers:  OncoCyte (NYSEMKT: OCX ) +228% . Voyager Therapeutics (NASDAQ: VYGR ) +36% . Conatus Pharmaceuticals (NASDAQ: CNAT ) +34% . Zynerba Pharmaceuticals (NASDAQ: ZYNE ) +33% . HyreCar (NASDAQ: HYRE ) +21% . Sanmina (NASDAQ: SANM ) +18% . Woodward (NASDAQ: WWD ) +17% . J &a...

CORAL GABLES, FL / ACCESSWIRE / January 24, 2019 / The pharma stock market was built on the framework and understanding that, as medical experts discover new diseases, companies in the sector are responsible for creating innovative treatment options to combat these ailments. It is for this...